Bloomberg BusinessweekBloomberg Businessweek

Travel Rebound Hindered by Delta Variant

View descriptionShare

Dr. Ian Lustbader, Clinical Professor of Medicine at NYU Langone, discusses the use of the drug ivermectin to treat Covid-19. Bloomberg Businessweek Editor Joel Weber shares stories from the new issue of Businessweek Magazine. Axel Hefer, CEO at Trivago, talks about the company's earnings and how new global virus cases are impacting the travel industry. And we Drive to the Close with Jay Hatfield, CEO at Infrastructure Capital Advisors.

Hosts: Carol Massar and Tim Stenovec. Producer: Paul Brennan.

  • Facebook
  • X (Twitter)
  • WhatsApp
  • Email
  • Download

In 1 playlist(s)

  1. Bloomberg Businessweek

    4,366 clip(s)

Bloomberg Businessweek

Carol Massar and Tim Stenovec bring together the latest news from the world of business and finance  
Social links
Follow podcast
Recent clips
Browse 4,369 clip(s)